Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997.
Saved in:
| Title: | Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997. |
|---|---|
| Authors: | Lucas DM; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA., Ruppert AS; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA., Lozanski G; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA., Dewald GW; b Mayo Clinic , Rochester , MN , USA., Lozanski A; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA., Claus R; c University of Freiburg Medical Center , Freiburg , Germany.; d German Cancer Research Center , Heidelberg , Germany., Plass C; d German Cancer Research Center , Heidelberg , Germany., Flinn IW; e Sarah Cannon Research Institute and Tennessee Oncology , Nashville , TN , USA., Neuberg DS; f Dana Farber Cancer Institute , Boston , MA , USA., Paietta EM; g Montefiore Medical Center , Bronx , NY , USA., Bennett JM; h University of Rochester , Rochester , NY , USA., Jelinek DF; b Mayo Clinic , Rochester , MN , USA., Gribben JG; i Barts Cancer Institute, Queen Mary University of London , London , UK., Hussein MA; j Celgene Corporation , Summit , NJ , USA., Appelbaum FR; k Fred Hutchinson Cancer Research Center , Seattle , WA , USA., Larson RA; l University of Chicago , Chicago , IL , USA., Moore DF Jr; m Cancer Center of Kansas , Wichita , KS , USA., Tallman MS; n Memorial Sloan Kettering Cancer Center , New York , NY , USA., Byrd JC; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA., Grever MR; a Ohio State University Comprehensive Cancer Center , Columbus , OH , USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2015; Vol. 56 (11), pp. 3031-7. Date of Electronic Publication: 2015 Mar 30. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.3109/10428194.2015.1023800 |
